GLP-1 RECEPTOR AGONISTS: A NEW ERA IN DIABETES MANAGEMENT

GLP-1 receptor agonists are emerging as a groundbreaking approach in the management of diabetes. These innovative retatrutide peptide medications mimic the actions of naturally occurring glucagon-like peptide-1 (GLP-1), a hormone that plays a crucial role in regulating blood sugar levels. By stimulating GLP-1 receptors, these drugs increase insulin